The oropharynx of men using HIV pre-exposure prophylaxis is enriched with antibiotic resistance genes: A cross-sectional observational metagenomic study

被引:5
|
作者
Van Dijck, Christophe [1 ,2 ]
Laumen, Jolein Gyonne Elise [1 ,2 ]
de Block, Tessa [1 ]
Abdellati, Said [1 ]
De Baetselier, Irith [1 ]
Tsoumanis, Achilleas [1 ]
Malhotra-Kumar, Surbhi [2 ]
Manoharan-Basil, Sheeba Santhini [1 ]
Kenyon, Chris [1 ,3 ]
Xavier, Basil Britto [2 ]
机构
[1] Inst Trop Med Antwerp, Dept Clin Sci, Nationalestr 155, B-2000 Antwerp, Belgium
[2] Univ Antwerp, Vaccine & Infect Dis Inst, Lab Med Microbiol, Univ Pl 1, B-2610 Antwerp, Belgium
[3] Univ Cape Town, ZA-7700 Cape Town, South Africa
关键词
Shotgun metagenomics; Shotgun; Resistome; Microbiome; Horizontal gene transfer; Transformation; Neisseria gonorrhoeae; Antimicrobial resistance; ANTIMICROBIAL RESISTANCE; IMPACT;
D O I
10.1016/j.jinf.2023.02.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Phenotypic studies have found high levels of antimicrobial resistance to cephalosporins, macrolides and fluoroquinolones in commensal Neisseria species in the oropharynx of men who have sex with men (MSM) using HIV pre-exposure prophylaxis (PrEP). These species include Neisseria subflava and Neisseria mucosa. This may represent a risk to pathogens like Neisseria gonorrhoeae which tend to take up antibiotic resistance genes (ARGs) from other bacteria. We aimed to explore to what extent the orophar-yngeal resistome of MSM using PrEP differed from the general population. Methods: We collected oropharyngeal swabs from 32 individuals of the general population and from 64 MSM using PrEP. Thirty-two MSM had consumed antibiotics in the previous six months, whereas none of the other participants had. Samples underwent shotgun metagenomic sequencing. Sequencing reads were mapped against MEGARes 2.0 to estimate ARG abundance. ARG abundance was compared between groups by zero-inflated negative binomial regression. Findings: ARG abundance was significantly lower in the general population than in MSM (ratio 0.41, 95% CI 0.26-0.65). More specifically, this was the case for fluoroquinolones (0.33, 95% CI 0.15-0.69), macrolides (0.37, 95% CI 0.25-0.56), tetracyclines (0.41, 95% CI 0.25-0.69), and multidrug efflux pumps (0.11, 95% CI 0.03-0.33), but not for beta-lactams (1.38, 95% CI 0.73-2.61). There were no significant differences in ARG abundance between MSM who had used antibiotics and those that had not. Interpretation: The resistome of MSM using PrEP is enriched with ARGs, independent of recent antibiotic use. Stewardship campaigns should aim to reduce antibiotic consumption in populations at high risk for STIs. (c) 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:329 / 337
页数:9
相关论文
共 50 条
  • [1] Initial implementation of HIV pre-exposure prophylaxis for people who are incarcerated in Zambia: a cross-sectional observational study
    Lindsay, Brianna
    Nyirongo, Nasho
    Mwango, Linah
    Toeque, Mona Gekanju
    Masumba, Carol
    Litongola, James Paul
    Sikanyika, James
    Kabombo, Henry
    Moyo, Martin
    Siachibila, Steven
    Mudenda, James
    Tembo, Kalima
    Olowski, Pawel
    Olufunso, Adebayo
    Muchinda, Elizabeth
    Musonda, Bupe
    Okuku, Jackson
    Mwila, Annie
    Moonga, Clement N.
    Herce, Michael E.
    Claassen, Cassidy
    Claassen, Cassidy W.
    LANCET HIV, 2023, 10 (01): : E24 - E32
  • [2] Factors associated with the informal use of HIV pre-exposure prophylaxis in Germany: a cross-sectional study
    Koppe, Uwe
    Marcus, Ulrich
    Albrecht, Stefan
    Jansen, Klaus
    Jessen, Heiko
    Gunsenheimer-Bartmeyer, Barbara
    Bremer, Viviane
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (10)
  • [3] Factors associated with hepatitis A susceptibility among men who have sex with men using HIV pre-exposure prophylaxis in Northeastern Brazil: A cross-sectional study
    Vechi, Hareton Teixeira
    Bay, Monica Baumgardt
    Silva de Freitas, Claudio Henrique
    Fernandes Costa de Sant'anna, Julia Gomes
    Brites, Carlos
    de Lima, Kenio Costa
    PLOS ONE, 2024, 19 (03):
  • [4] Pre-exposure prophylaxis use, HIV knowledge, and internalized homonegativity among men who have sex with men in Brazil: A cross-sectional study
    Blair, Kevin J.
    Torres, Thiago S.
    Hoagland, Brenda
    Bezerra, Daniel R. B.
    Veloso, Valdilea G.
    Grinsztejn, Beatriz
    Clark, Jesse
    Luz, Paula M.
    LANCET REGIONAL HEALTH-AMERICAS, 2022, 6
  • [5] Related barriers to using HIV pre-exposure prophylaxis among MSM: A multicentre cross-sectional survey
    Yang, Xue
    Zhang, Guang
    Kang, Wenting
    Guo, Jiahuan
    Liu, An
    Tang, Houlin
    Liu, Tongtong
    Sun, Lijun
    HIV MEDICINE, 2024,
  • [6] Pre-exposure prophylaxis for HIV in Austria: A prospective observational study
    Chromy, D.
    Neidhart, T.
    Urban, N.
    Grabmeier-Pfistershammer, K.
    Touzeau-Roemer, V.
    Saluzzo, S.
    Esser, S.
    Weninger, W.
    Willinger, B.
    Rieger, A.
    Bauer, W. M.
    HIV MEDICINE, 2023, 24 : 497 - 498
  • [7] Antibiotic Prophylaxis for VCUG: A Cross-Sectional Observational Study
    Suprita Kalra
    S. K. Dey
    R. Shankar
    Madhuri Kanitkar
    The Indian Journal of Pediatrics, 2020, 87 : 238 - 238
  • [8] Antibiotic Prophylaxis for VCUG: A Cross-Sectional Observational Study
    Kalra, Suprita
    Dey, S. K.
    Shankar, R.
    Kanitkar, Madhuri
    INDIAN JOURNAL OF PEDIATRICS, 2020, 87 (03): : 238 - 238
  • [9] Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin - A multicentre, cross-sectional survey
    Werner, Ricardo Niklas
    Gaskins, Matthew
    Ahrens, Jens
    Jessen, Heiko
    Kutscha, Frank
    Mosdzen, Regina
    Osswald, Wolfgang
    Sander, Dirk
    Schellberg, Sven
    Schwabe, Kai
    Wuensche, Thomas
    Dressler, Corinna
    Sammons, Mary
    Nast, Alexander
    PLOS ONE, 2018, 13 (09):
  • [10] Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
    Koppe, Uwe
    Marcus, Ulrich
    Albrecht, Stefan
    Jansen, Klaus
    Jessen, Heiko
    Gunsenheimer-Bartmeyer, Barbara
    Bremer, Viviane
    BMC PUBLIC HEALTH, 2021, 21 (01)